Martine van Vugt

Director/Board Member presso SCANDION ONCOLOGY A/S

71 anni

Health Technology

Consumer Services

Profilo

Martine J.
van Vugt is currently an Independent Director at Scandion Oncology A, a Director at Hollandbio, the Chief Strategy Officer & Executive Vice President at Genmab A, an Independent Member-Supervisory Board at TME Pharma NV, and a Member-Supervisory Board at Immagene BV.
Dr. van Vugt holds a doctorate degree from the University of Utrecht and a graduate degree from Wageningen University.

Posizioni attive di Martine van Vugt

Società	Posizione	Inizio
GENMAB A/S	Corporate Officer/Principal	29/03/2023
TME PHARMA N.V.	Director/Board Member	24/06/2021
SCANDION ONCOLOGY A/S	Director/Board Member	01/04/2022
Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	Director/Board Member	-
Hollandbio	Director/Board Member	-

Tutte le posizioni attive di Martine van Vugt

Formazione di Martine van Vugt

University of Utrecht	Doctorate Degree
Wageningen University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Martine van Vugt

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
GENMAB A/S	Health Technology
TME PHARMA N.V.	Health Technology
SCANDION ONCOLOGY A/S	Health Technology

Aziende private	2
Hollandbio
Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	Health Technology